Global Metal Partially Covered Biliary Stent Market Size By Type (Absorbable, Non Absorbable), By Application (Hospital, Medical Center), By Region, And Segment Forecasts, 2023 to 2032

lobal Metal Partially Covered Biliary Stent Market Report Description

The Global Metal Partially Covered Biliary Stent Market was valued at USD 215 million in 2023 and is projected to surpass USD 386 million by 2031, growing at a CAGR of 7.4% during the forecast period from 2023 to 2031. The market is experiencing significant growth due to rising incidences of biliary tract diseases, increasing preference for minimally invasive procedures, and continuous advancements in stent technology. Metal partially covered biliary stents are widely used for palliative treatment of malignant biliary obstructions, providing optimal radial force and prolonged patency with reduced risks of tissue ingrowth.

Drivers:

1. Increasing Prevalence of Biliary Tract Cancers:

The growing global burden of liver and pancreatic cancers is driving the need for effective palliative treatment options. Metal partially covered stents are increasingly being used to relieve biliary obstructions caused by malignancies.

2. Shift Toward Minimally Invasive Procedures:

Minimally invasive endoscopic treatments are being widely adopted due to reduced recovery time, lower complication rates, and better patient outcomes, boosting the demand for biliary stents.

3. Advancements in Stent Design:

Manufacturers are developing stents with enhanced flexibility, biocompatible coatings, and anti-migration features, making them more effective and safer, which is accelerating market growth.

Restraints:

1. Risk of Stent Migration and Occlusion:

Despite technological improvements, the partially covered design may still pose challenges like stent migration or sludge formation, affecting long-term efficacy.

2. High Procedure and Device Cost:

The overall cost of stent placement, including imaging, hospitalization, and device cost, can be high, especially in low-resource settings, limiting widespread adoption.

Opportunity:

1. Emerging Markets and Healthcare Expansion:

Increasing healthcare infrastructure and government support in developing regions such as Asia-Pacific and Latin America are creating lucrative opportunities for market players.

2. Innovation in Coating Materials:

The development of drug-eluting and biodegradable coatings for biliary stents offers a significant opportunity to enhance performance and reduce complications, attracting investment and research focus.

Market by System Type Insights:

By system type, Self-Expandable Metal Stents (SEMS) dominated the market in 2023. SEMS are favored for their high radial strength, ease of deployment, and longer patency rates compared to plastic stents. Within this, the partially covered SEMS segment holds a leading share, offering a balance between reducing tumor ingrowth and minimizing migration risk.

Market by End-Use Insights:

In 2023, hospitals accounted for the largest revenue share. The increasing number of endoscopic retrograde cholangiopancreatography (ERCP) procedures performed in hospital settings, due to better infrastructure and skilled personnel, underpins this dominance. Ambulatory surgical centers (ASCs) are expected to witness faster growth due to reduced procedure costs and shorter patient stays.

Market by Regional Insights:

North America led the global market in 2023, driven by high healthcare expenditure, early adoption of advanced stent technologies, and favorable reimbursement policies. However, Asia-Pacific is projected to experience the highest growth rate, attributed to rising cancer incidence, growing awareness, and improved access to endoscopic care in countries like China, India, and South Korea.

Competitive Scenario:

Key players in the global metal partially covered biliary stent market include:

Boston Scientific Corporation

Cook Medical

Taewoong Medical Co., Ltd.

Micro-Tech (Nanjing) Co., Ltd.

Medtronic Plc

Becton, Dickinson and Company (BD)

Olympus Corporation

CONMED Corporation

These companies are investing in R&D, expanding their distribution networks, and launching technologically advanced products to gain competitive advantage. For instance:

In 2023, Boston Scientific launched an upgraded partially covered stent with enhanced anti-migration features.

Taewoong Medical expanded its stent product portfolio targeting complex malignant obstructions in the biliary tract.

Scope of Work – Global Metal Partially Covered Biliary Stent Market

Report Metric Details

Market Size (2023) USD 215 million

Projected Market Size (2031) USD 386 million

CAGR (2023–2031) 7.4%

Market Segments By System Type (SEMS, FCSEMS, PCSEMS), By End-use (Hospitals, ASCs, Specialty Clinics), By Region

Growth Drivers Rise in biliary tract cancers, minimally invasive procedures, stent innovations

Opportunities Emerging markets, biodegradable and drug-eluting stents

Key Market Developments:

June 2023: Boston Scientific received FDA clearance for its latest partially covered biliary stent, designed to reduce tumor ingrowth while maintaining drainage.

March 2024: Cook Medical launched a new stent delivery system optimized for precision placement in tortuous anatomies.

January 2025: Taewoong Medical signed a strategic distribution agreement across Latin America to enhance access to its advanced biliary stent portfolio.

FAQs:

1) What is the current market size of the Global Metal Partially Covered Biliary Stent Market?

The market was valued at USD 215 million in 2023.

2) What is the major growth driver of the Global Metal Partially Covered Biliary Stent Market?

The increasing prevalence of biliary tract cancers and adoption of minimally invasive procedures are the primary growth drivers.

3) Which is the largest region during the forecast period in the Global Metal Partially Covered Biliary Stent Market?

North America holds the largest market share, while Asia-Pacific is expected to grow at the fastest rate.

4) Which segment accounted for the largest market share in Global Metal Partially Covered Biliary Stent Market?

The Self-Expandable Metal Stents (SEMS) segment, particularly partially covered variants, accounted for the largest share.

5) Who are the key market players in the Global Metal Partially Covered Biliary Stent Market?

Key players include Boston Scientific, Cook Medical, Taewoong Medical, Micro-Tech, Medtronic, BD, Olympus, and CONMED.

Let me know if you'd like this in a downloadable format or tailored for presentation use.